ProtoKinetix Reaches Mid-Point of 3rd Stage of Retinal Cell Replacement Therapy Testing at UBC

14

MARIETTA, Ohio–(BUSINESS WIRE)–#AAGP–ProtoKinetix Reaches Mid-Point of 3rd Stage of Retinal Cell Replacement Therapy Testing at UBC

 

 

 

http://www.businesswire.com/news/home/20190709005322/en/ProtoKinetix-Reaches-Mid-Point-3rd-Stage-Retinal-Cell/

 

- Advertisement -